Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency (Details 1)

v2.4.0.8
Stockholders' Deficiency (Details 1) (USD $)
9 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Exercise Price $ 0.57 $ 0.21
Outstanding Number of Warrants 8,503,159 2,812,498
Weighted Average Remaining Life In Years 4 years 6 months  
Exercisable Number of Warrants 6,459,324  
Exercise Price One [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Exercise Price $ 0.001  
Outstanding Number of Warrants 2,043,835  
Weighted Average Remaining Life In Years 0 years  
Exercisable Number of Warrants 0  
Exercise Pirce Two [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Exercise Price $ 0.750  
Outstanding Number of Warrants 6,459,324  
Weighted Average Remaining Life In Years 4 years 6 months  
Exercisable Number of Warrants 6,459,324